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ABSTRACT: Introduction: Since 2003, the access to medication has been increasing in Brazil and particularly 
in São Paulo. The present study aimed to analyze the access to medication obtained in the public sector and 
the socioeconomic differences in this access in 2003 and 2008. Also, we explored the difference in access to 
medication from 2003 to 2008. Method: Data were obtained from two cross-sectional population-based household 
surveys from São Paulo, Brazil (ISA-Capital 2003 and ISA-Capital 2008). Concentration curve and concentration 
index were calculated to analyze the associations between socioeconomic factors and access to medication in 
the public sector. Additionally, the differences between 2003 and 2008 regarding socioeconomic characteristics 
and access to medication were studied. Results: Access to medication was 89.55% in 2003 and 92.99% in 2008, 
and the proportion of  access to medication did not change in the period. Access in the public sector increased 
from 26.40% in 2003 to 48.55% in 2008 and there was a decrease in the concentration index between 2003 and 
2008 in access to medication in the public sector. Conclusions: The findings indicate an expansion of  Brazilian 
Unified Health System (Sistema Único de Saúde) users, with the inclusion of  people of  higher socioeconomic 
position in the public sector. As the SUS gives more support to people of  lower socioeconomic position in 
terms of  medication provision, the SUS tends to equity. Nevertheless, universal coverage for medication and 
equity in access to medication in the public sector are still challenges for the Brazilian public health system.
Keywords: Healthcare disparities. Medication systems. Equity in health. Equity in access. Pharmaceutical 
services. Universal access to health care services.
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INTRODUCTION
The public health care system in Brazil is universal and aims to provide vaccination, phar-
maceutical care, general practice, medical specialists, hospital care, dental care and others 
health care services to all1. The Brazilian Unified Health System (Sistema Único de Saúde – SUS) 
is a dynamic and complex health system which aims to provide comprehensive, universal, 
preventive and curative care through the provision of  health services1,2. 
The pharmaceutical care system in Brazil is one of  the most complex services in the 
world3,4. In 1998, the government approved the National Medicines Policy5, based on 
Pharmaceutical Assistance Reorientation, in an attempt to promote access to, and the 
rational use of, medicines. The public sector covers medication that is listed as “essential 
medication”, i.e. medication to treat the most prevalent diseases in Brazil and included in 
Ministry of  Health pharmaceutical care list, the National Essential Medicines List (Rename)4. 
Medications included in Rename are considered basic and indispensable for most population 
health problems. Rename should also guide the standardization, prescription and supply of  
medicines, mainly within SUS5,6.
Universal access to essential medication was standardized by SUS in 1998 and there has 
been an increase in the supply of  medication for health care since this date4. Brazilian national 
pharmaceutical policies since 1998 include programs which aim to improve access to medi-
cation in Brazil such as the Generic Drug Policy7 and the Programa Farmácia Popular do Brasil 
(Popular Drugstore program)3,4, and also Dose Certa 8, Remédio em casa 9 and HiperDia10.
RESUMO: Introdução: Desde 2003, o acesso da população a medicamentos tem aumentado no Brasil e particularmente 
em São Paulo. O estudo visou analisar o acesso a medicamentos obtidos do setor público e as desigualdades 
socioeconômicas nesse acesso em 2003 e em 2008. Método: Os dados são provenientes dos inquéritos domiciliares 
de saúde ISA-Capital, realizados na cidade de São Paulo em 2003 e em 2008. Foi feita Regressão Logística para 
analisar os fatores associados ao acesso a medicamentos. A análise das desigualdades no acesso a medicamentos 
foi feita a partir da Curva de Concentração e Índice de Concentração. Adicionalmente, as diferenças entre os anos 
de 2003 e 2008 com relação às características socioeconômicas e ao acesso a medicamentos foram estudadas. 
Resultados: O acesso a medicamentos foi 89,55% em 2003 e 92,99% em 2008. O acesso a medicamentos pelo setor 
público aumentou de 26,40% em 2003 para 48,55% em 2008 e foi maior na população com menor poder aquisitivo, 
porém houve mudança no índice de concentração entre 2003 e 2008. Conclusões: Os achados indicam a expansão 
da clientela do Sistema Único de Saúde na cobertura de medicamentos, com a entrada da população com maior 
poder aquisitivo no setor público. O acesso continua maior na população com menor poder aquisitivo, o que sugere 
que o SUS tenta a equidade na provisão de medicamentos. Entretanto, a cobertura universal para gastos com 
medicamentos essenciais e a equidade no acesso a medicamentos pelo setor público ainda são desafios para o SUS.
Palavras-chave: Disparidades em assistência à saúde. Sistemas de medicação. Equidade em Saúde. Assistência 
farmacêutica. Acesso universal a serviços de saúde.
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Despite these public programs to improve access to medication, guaranteeing access to 
essential medicines is still a challenge in Brazil6. Access is influenced by sociodemographic 
and socioeconomic factors11. Among the socioeconomic factors, cost is one of  the main 
barriers to obtaining medication12. Within the health care budget in Brazil, around 30% of  
health care expenditure is on medication12. The proportion of  medication expenditure on 
the low income population is significantly higher than that spent on the high income pop-
ulation12,13. This may reflect the socioeconomic and health inequalities in Brazil generally 
and particularly in São Paulo, which has considerable and persistent inequalities, with a Gini 
Coefficient14 of  0.57 in 1991, 0.62 in 2000 and 0.65 in 201013.
There has been an increase in the provision of  medication in the public sector due to 
the programs mentioned above and income disparities in access to medication3,5,6. It is 
important to analyze medication coverage in the public sector in relation to socioeco-
nomic inequalities. The present study aimed to analyze access to medication and socio-
economic differences in access to medication covered by the public sector in São Paulo 
in 2003 and in 2008. In addition, the study explored the difference in access to medica-
tion from 2003 to 2008.
METHODS
Data comes from two cross-sectional population-based household surveys Inquéritos de 
Saúde no município de São Paulo (ISA-Capital) 2003 and ISA-Capital 2008, that investigated 
the living conditions, health status and access to health care services of  non-institutional-
ized residents of  São Paulo, Brazil.
The methodologies used in the two surveys were based on probability samples15,16. 
In 2003, 60 sectors were randomly sampled from the 264 census tracts, previously selected 
by the Instituto Brasileiro de Geografia e Estatística (IBGE)17 for the Brazilian Household Survey. 
In 2008, 70 sectors were randomly sampled from the 267 census tracts selected by the IBGE18 
for the Brazilian Household Survey. 
In 2003, the census tracts were stratified according to education level (lower, middle, 
higher), defined by the educational level of  the head of  each household. The desired 
number of  tracts was then selected. In the second stage, households were sampled 
from the selected tracts in order to obtain an adequate sample size for each domain. 
The domains were based on gender (male, female) and age group (< 1 year, 1 – 11 years, 
12 – 19 years, 20 – 59 year, > 60 years). In 2008, the census tracts were stratified accord-
ing to age and gender.
A stratified sample of  420 respondents in each domain was approached for interview. 
The response rate was 78.62% in 2003 and 76.41% in 2008. In 2003, 3,357 people were inter-
viewed, and 3,271 were interviewed in 2008. Strategies to ensure the quality and consistency 
of  data included close supervision of  interviewers in the field, review of  all questionnaires, 
and re-interviewing of  5% of  participants. 
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The surveys were financed by the Municipal Health Secretary of  São Paulo. Researchers 
from three universities in São Paulo state (Universidade de São Paulo, Universidade Estadual de 
Campinas and Universidade Estadual Paulista “Júlio de Mesquita Filho”) participated in the sur-
veys. The Research Ethics Committee of  the University of  São Paulo approved the design 
and conduct of  the study. 
The design and characteristics of  ISA-Capital 2003 and ISA-Capital 2008 are described 
in detail at: http://www.fsp.usp.br/isa-sp
The following demographic factors were examined: age (0 – 11 years, 12 – 19 years, 
20 – 59 years and 60 or more) and gender. 
The socioeconomic factors studied were: ethnicity (Caucasian when respondents 
reported white and non-Caucasian when respondents reported black/mixed/other), 
housing condition, education (0 – 3, 4 – 11 and 12 or more years of  study), income 
(monthly family income per head), classified as ≤ 2.00, > 2.00 to 4.99 and ≥ 5.00 min-
imum legal wage (mlw), in 2003 and in 2008. In 2008, the variable “having a private 
health plan” was also studied. 
We did not adjust the variable monthly family income per head (income) for inflation. 
The minimum legal wage in 2003 was R$ 240.00, and in 2008, R$ 415.00. Housing condi-
tion was divided into adequate or inadequate; it was considered adequate when the house 
had piped water from the public network, had electric lighting, was connected to the sewer 
system and had an internal lavatory. When any of  these factors was not present, the hous-
ing was considered inadequate. 
The outcomes considered in this study were: 
• Access to medication prescribed in the health care service – respondents who 
had used health care services in the last two weeks were asked whether they had 
been prescribed medication and whether they had had access to medication. 
Respondents were categorized as “had access to medication prescribed in health 
care service” and “did not have access to medication prescribed in health care 
service”. If  more than one medication was prescribed and the respondent had 
access to at least one of  them, it was categorized as “had access to medication 
prescribed in health care service”.
• Access to medication in the public sector – we are interested in whether the prescribed 
medications were financed by the public sector (SUS) or by the private sector (e.g. 
private health insurance). Respondents who had used health care services in the 
previous two weeks and had had access to medication were asked whether this 
medication was provided by the public or private sector. 
The samples ISA-Capital 2003 and ISA-Capital 2008 were weighted to compensate for 
the different selection probabilities. Weighting was done at the individual level, the sec-
tors were weighted for access to different sampling fractions in the strata. The differences 
between 2003 and 2008 regarding socioeconomic characteristics/health status and access 
to medication were analyzed by corrected Satterthwaite χ2 tests. 
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Crude and adjusted logistic regressions were used to explore the associations between 
socioeconomic factors/health status and access to medication in the public sector. The model 
0 represents the crude odds ratio (OR) between socioeconomic factors and access to medi-
cation and model 1 was adjusted by age and gender. Significance was judged using α = 0.05.
A concentration curve adjusted for sociodemographic factors was used to explore the 
associations between income and access to medication in the public sector. On the graph, 
a straight diagonal line represents perfect equality of  distribution; the concentration curve 
line beneath or above shows the reality of  the distribution. The concentration curve is a 
function of  the cumulative proportion of  ordered individuals mapped onto the correspond-
ing cumulative proportion of  their size; a larger area implies major inequality19. In the pres-
ent study, the concentration curve plots cumulative income by access to medication in the 
public sector adjusted for age, gender and chronic disease. 
Concentration index (ci), which is directly related to concentration curve, was used to 
measure the degree of  socioeconomic inequalities in access to medication in the public sec-
tor in 2003 and in 2008. The concentration index is defined as twice the area between the 
concentration curve and the line of  equality (the 45-degree line). If  there is no socioeco-
nomic-related inequality, the concentration index is zero. The convention is that the index 
takes a negative value when the curve lies above the line of  equality, indicating a dispropor-
tionate concentration of  the health variable among the poor, and a positive value when it 
lies below the line of  equality20.
Concentration curve and concentration index were analyzed as indicated by Wagstaff 
et al.21. Analyses were carried out in Stata 12.0 using the survey package, which considers 
the effects of  complex study design and allows the different weights of  the observations to 
be embedded. 
RESULTS
Table 1 shows the descriptive results of  the sample and differences between 2003 and 
2008. Socioeconomic factors and health status did not change between 2003 and 2008. Access 
to medication was high in 2003 (89.55%) and in 2008 (92.99%). Access to medication in the 
public sector increases from 26.40% in 2003 to 48.55% in 2008, and the change is significant. 
Table 2 shows access to medication in the public sector in 2003 and in 2008 by categories 
of  education, income, housing condition and ethnicity. Access to medication in the public 
sector adjusted for age and gender was higher in non-Caucasians in 2003. In 2008, access 
in the public sector was higher in people with lower education, lower income and in those 
without a private health plan.
Regarding socioeconomic differences in access to medication in the public sector, in 2003 
the concentration index was -0.63 (Standard Deviation (SD) = 0.134; Confidence Interval 
(CI) = 95%CI -0.37 – -0.88). In 2008, it was -0.52 (SD = 0,132; 95%CI -0.26 – -0.77). Figures 1 
and 2 show the concentration curves for 2003 and 2008, respectively. 
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Table 1. Characteristics of the ISA-Capital 2003 and ISA-Capital 2008 respondents living in the 
city of São Paulo, Brazil.
Socioeconomic and sociodeographic 
factors and Access to medication
2003
n (%)
2008
n (%)
Difference
2003-2008
(p-value)*
Sociodemographic factors
Age group (years) 0.254
0 – 11 843 (19.78) 580 (19.73)
12 – 19 847(15.05) 605 (12.15)
20 – 59 795 (54.76) 1162 (57.00)
≥ 60 872 (10.42) 924 (11.12)
Gender 0.347
Male 1678 (47.46) 1444 (47.44)
Female 1679 (52.54) 1827 (52.56)
Socioeconomic factors
Ethnicity 0.111
Caucasian 2138 (65.08) 2002 (61.94)
Non-caucasian 1146 (34.92) 1263 (38.06)
Education (years of study) 0.278
0 – 3 620 (13.61) 9.12 (487)
4 – 11 2300 (67.59) 2375 (71.18)
12+ 389 (18.80) 389 (19.69)
Income (minimum legal wage) 0.521
≤ 2 1130 (35.77) 1243 (39.19)
> 2 to 5 867 (28.88) 839 (31.14)
≥ 5 900 (35.36) 644 (29.66)
Housing condition
Adequate 2688 (80.05) 2742 (85.83) 0.217
Inadequate  669 (19.95) 529 (14.17)
Access to medication
Access to medication prescribed in health  care service 354 (89.55) 287 (92.99) 0.175
Access to medication in public sector 102 (26.40) 137 (48.55) 0.001
*The differences between 2003 and 2008 were analyzed by corrected Satterthwaite χ2 tests.
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2003 2008
Access to 
medication 
in private 
sector
 (n = 252) 
n (%)
Access to 
medication in 
public sector 
(n = 102) 
n (%)
Access to 
medication in 
public sectora –
Crude OR 
(95%CI)
Access to 
medication in 
public sectora –
Adjusted ORb 
(95%CI)
Access to 
medication 
in private 
sector 
(n = 150)
n (%)
Access to 
medication in 
public sector 
(n = 137) 
n (%)
Access to 
medication in 
public sectora –
Crude OR 
(95%CI)
Access to 
medication in 
public sectora –
Adjusted ORb
(95%CI)
Educationc
0 – 3 40 (66.60) 29 (33.40) 1 1 17 (41.98) 24 (58.02) 1 1
4 – 11 163 (68.18) 72 (31.82)
0.93 
(0.43 – 2.02)
0.98 
(0.42 – 2.27)
108 (46.81) 108 (53.19)
0.82 
(0.37 – 1.84)
0.63 
(0.25 – 1.57)
≥ 12 46 (100) 0 - - 25 (80.05) 4 (19.95)
0.18 
(0.06 – 0.56)
0.12 
(0.03 – 0.42)
Incomec 
≤ 2 24 (69.75) 18 (30.25) 1 1 16 (40.45) 23 (59.55) 1 1
2.1 – 4.99 93 (70.99) 46 (29.01)
0.94 
(0.37 – 2.80)
0.93 
(0.43 – 2.01)
72 (47.97) 72 (52.03)
0.74 
(0.29 – 1.84)
0.67 
(0.25 – 1.82)
≥ 5 101 (83.45) 17 (16.55) 0.40 
(0.18 – 1.17)
0.41 
(0.15 – 1.15)
35 (77.01) 9 (22.99)
0.20 
(0.06 – 0.70)
0.20 
(0.05 – 0.73)
Housing condition
Adequate 217 (74.49) 79 (25.51) 1 1 137 (53.33) 108 (46.67) 1 1
Inadequate 35 (67.35) 23 (32.65)
1.41 
(0.66 – 3.03)
1.36 
(0.61 – 3.03)
14 (35.86) 29 (64.14)
2.04 
(0.95 – 4.41)
2.05 
(0.93 – 4.49)
Ethnicity
Caucasian 178 (81.23) 53 (18.77) 1 1 103 (55.47) 75 (44.53) 1 1
Non-caucasian 73 (61.31) 49 (38.69)
2.74 
(1.38 – 5.39)
2.71 
(1.40 – 5.31)
48 (45.30) 62 (54.70)
1.52 
(0.62 – 2.72)
1.48 
(0.93v2.84)
Private health pland
No 45 (26.30) 120 (73.70) 1 1
Yes 106 (84.80) 17 (15.20)
0.06 
(0.03 – 0.13)
0.05 
(0.03 – 0.120
Table 2. Crude and adjusted logistic regression for access to medication in the public sector and socioeconomic characteristics. São Paulo, 2003 and 2008.
a The focus of the present study is on access in the public sector. bAdjusted by age and gender. c Missings were excluded. d People with private health plan also can use 
public sector to obtain medication. 
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Figure 2. Access to medication from public sector adjusted for age, and gender. Concentration curve. 2008.
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Figure 1. Access to medication from public sector adjusted for age and gender. Concentration curve. 2003.
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DISCUSSION 
Access to medication has been improving in Brazil. Among the aims of  the Brazilian 
Health System is a decrease in the socioeconomic disparities between individuals, which 
includes equity in access to medication. Deeper knowledge about access to, and coverage 
of, medication is important to inform public policies to achieve this aim.
We acknowledge several limitations to this study. The small study population can be 
inferred from our analyses. As our data only relate to medication prescribed in the health 
care service, the study of  access to medication is limited to this population.  We do not know 
about the reasons for lack of  access to medication and we are not able to discuss the qual-
ity of  pharmaceutical care in the public sector in this study. Finally, we do not know about 
medication costs, or if  the medication prescribed is “high cost” or “low cost”. If  more than 
one medication was prescribed and the respondent had access to at least one of  them, they 
were categorized as “access to medication prescribed in health care service”, but it is pos-
sible the respondent was prescribed an expensive medication and a cheaper one but only 
had access to the cheaper item.
Education, income and housing condition did not change between 2003 and 2008. Although 
several economic changes have been occurring in Brazil since 2003, the socioeconomic char-
acteristics did not change between 2003 and 2008. We did not observe any of  these changes 
in São Paulo during the short period 2003 – 2008 in the present study. 
Access to medication obtained in both the public and private sector was very high in 
both years (89.55 and 92.99%, respectively), and the proportion of  access to medication did 
not change between 2003 and 2008. Similar results were found in a study of  another capi-
tal in Brazil, which shows access to medication in general was 95.8%22. Access to medica-
tion has a high impact on health services because it is a basic ingredient of  the therapeutic 
process. This access must be adequate, timely, good quality, equitably distributed and effi-
ciently organized23.
There was an increase in the proportion of  access to medication in the public sector, 
from 26.40 in 2003 to 48.55 in 2008, and it was significant. Many factors may have influ-
enced this increase in access to medication. Among them, the expansion of  health policies 
for medication provision, changes in income distribution in population and judicialization 
of  pharmaceutical care.
Health policies, such as Generic Drug Policy, HiperDia, Popular Drugstore program, Dose 
Certa and Remédio em casa, have influenced the increase in access to medication3,5-7. These pro-
grams offer medication at lower cost or cost-free to people at all levels of  income. In some 
cases, there are problems such as program overlaps and unclear definition of  responsibil-
ities of  municipalities and states in medication provision6; nevertheless, the programs for 
medication provision have increased access to medication in São Paulo and also promoted 
the decrease in inequalities in access to medication4,5. 
Although it is a less significant influence, the judicialization of  pharmaceutical care also 
has increased access to medication in the public sector24,25. There has been an increase in 
ACCESS TO MEDICATION IN THE PUBLIC SECTOR AND EQUITY: POPULATIONAL HEALTH SURVEYS IN SÃO PAULO, BRAZIL
35
REV BRAS EPIDEMIOL JAN-MAR 2016; 19(1): 26-37
the number of  lawsuits concerning access to medication brought against the State Health 
Department since the creation of  SUS25. Deficiencies in access of  SUS users to essential med-
ication and also in access to drugs not included in Ministry of  Health pharmaceutical care 
lists are solved, in most cases, by the legal process 24,25. The judicialization of  pharmaceutical 
care, mainly for higher cost medication, has influenced the decrease in inequality. There are 
currently 392,000 lawsuits demanding action relating to health in Brazil26; most are for medi-
cation and have been brought by both the lower income and higher income populations24,25.
There has been an increase in the number of  private health plans in Brazil1, particularly 
in São Paulo. There has also been an increase in private health plans which cover only the 
doctor’s consultation12,13, which can increase the use of  the public sector to obtain medica-
tion; people can see a doctor in the private sector and get medication from the public sec-
tor. According to our study, almost half  the population had a private health plan in 2008. 
Nowadays, 60.00% of  the population of  São Paulo (6.7 million of  people) have a private 
health plan12,13. Among them, there are plans with high cost and low cost that do not cover 
provision of  medication. People with these plans obtain their medication in the public sector.
Access to medication in the public sector was 48.55% in 2008. These results show similar 
access in the public sector to that found in another state capital in Brazil in 2009, which shows 
access to medication among the elderly through the public sector to be 50.30%22. A study in 
Ribeirão Preto, São Paulo State in Brazil, showed provision of  medication in the public sec-
tor was 60.3%27. Similar results were also found by a Brazilian study of  11 cities, that showed 
only 55.40% of  the medication investigated was available in public health services28. According 
Silva et al.29, among people that used health care service in Brazil, 56.70% were in the public 
sector (and 43.30% in the private sector). The authors studied use of  the health care service 
including consultations, hospitalizations and vaccination. A similar result was found by Gomez-
Dantés et al.30, who studied the availability of  some essential drugs at primary health care units 
of  the public sector in Mexico and found a low supply of  essential drugs in the health units. 
The change in concentration index from -0,63 in 2003 to -0,52 in 2008 indicates that there 
was an expansion of  SUS users. The higher income population started to use the SUS or the 
inclusion in the public sector of  the population that previously only used the private sector 
can explain the increasing use of  the public sector to obtain medication. 
However, despite the increase in access to medication in the public sector by higher 
socioeconomic groups between 2003 to 2008, the lower socioeconomic groups were much 
more often covered by the public sector than the higher socioeconomic groups. Access to 
medication in the public sector was greater among those with lower income and among 
non-Caucasians in 2003, and among those with lower education, lower income, inadequate 
housing condition, non-Caucasians and those without private health plans in 2008.
Coverage of  medication in the public sector is very important, particularly in the lower 
income population as in some cases these people cannot buy medication and depend on 
SUS. Designing a universal health insurance system is a complicated process and success 
depends on organizational and financial arrangements. In order to be a universal system, 
it is important that access to health care services, and particularly to medication, expand in 
order to eliminate or minimize out-of-pocket expenditure by the poorest citizens31.
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In order to achieve equity, equal access is seen as equal use for those in equal need32. 
People of  low socioeconomic position are also likely to need more coverage by the public 
sector. Therefore, if  inequalities in access to health care are of  interest, it is important that 
the public sector attends people of  lower income in order to adjust for this unequal need. 
The results of  the present study show that the lower income population are supported by 
SUS to access medication and therefore the SUS tends to equity and is trying to universal-
ize access to medication.
CONCLUSIONS
The present study provides insights into the socioeconomic factors associated with access to 
medication in the public sector and access to medication in São Paulo. Knowledge about inequal-
ities in access to medication in the public sector is important to inform health policies to con-
tribute to reducing inequalities in health care services use and must be investigated more deeply.
The findings indicate that access to medication was high in the period studied, and people 
with lower education and lower income are supported by SUS to get medication, therefore 
the SUS tends to equity and is trying to universalize access to medication. Otherwise, the 
provision of  medication in the public sector increased from 2003 to 2008, with SUS coverage 
expansion to include people with higher income. Implementation and expansion of  pub-
lic programs for medication provision also contribute to explaining the increase. However, 
universal coverage of  medication and equity in access to medication in the public sector 
are still challenges to SUS.
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